![Training cover](https://storage.googleapis.com/platform-dev/uploads/files/R1UEuYY6fxxmnUUC95jP3VNjSy6Jy0l1Aww1yIJa.jpg)
MDR NONDEHP DISTRIBUTORS
Gratuit
Diffusion
En ligne
![Department Logo](https://storage.googleapis.com/platform-dev/uploads/files/kBqddQBVMXC4WDI9To9MrW85fyLbrIVykCozMjQC.jpg)
À propos Intervenants Public cible Avis
À propos
500 places par session
Anglais
Macopharma decided to ban DEHP and implement a new solution.
The webinar aims at informing partners on the new alternative proposed, related published performances as well as industrial plan to envision the transition jointly.
- 3 pm: The ban of DEHP - Caroline HERNU, CEO Macopharma
- 3:15 pm: New solution - Martin ROBIQUET, Marketing Director
- 3:30 pm: Scientific Pathway - Ignacio ALVAREZ, Medical Affairs Director
- 3:50 pm: Transition to non DEHP - Frank Schönfeld, Sales and Marketing Director
- 4 pm: Discussion, Questions and Answers
Intervenants
![Speaker Avatar](https://storage.googleapis.com/platform-dev/uploads/avatars/avatar_1698679069.png)
Caroline Hernu CEO - Macopharma
![Speaker Avatar](https://storage.googleapis.com/platform-dev/uploads/avatars/avatar_1698679251.jpg)
Ignacio Alvarez Medical Affairs Director
![Speaker Avatar](https://storage.googleapis.com/platform-dev/uploads/avatars/avatar_1698679622.jpg)
Martin Robiquet Blood Processing Solutions Marketing Director
![Speaker Avatar](https://storage.googleapis.com/platform-dev/uploads/avatars/avatar_1698679758.png)
Frank Schönfeld Macopharma Chief Commercial Officer
Public cible
L’évènement est à destination des praticiens ou spécialités ci-dessous :
Autre
Les avis de vos pairs sur Macopharma
Appréciation générale
4.7 · 15 Avis
Connaissances acquises
4.7
Organisation
4.7
Pédagogie
4.6
Recommandation
4.8
Contactez l’équipe Invivox
Discussion instantanée
- Chat disponible en bas à gauche
Gratuit
Cet évènement n'est plus disponible
![Department Logo](https://storage.googleapis.com/platform-dev/uploads/files/kBqddQBVMXC4WDI9To9MrW85fyLbrIVykCozMjQC.jpg)